Cargando…

Would New SARS-CoV-2 Variants Change the War against COVID-19?

The scientific, private, and industrial sectors use a wide variety of technological platforms available to achieve protection against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), including vaccines. However, the virus evolves continually into new highly virulent variants, which migh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Redwan, Elrashdy M., Elrashdy, Fatma, Aljabali, Alaa A. A., Baetas-da-Cruz, Wagner, Barh, Debmalya, Brufsky, Adam M., Hassan, Sk. Sarif, Lundstrom, Kenneth, Serrano-Aroca, Ángel, Takayama, Kazuo, Tambuwala, Murtaza M., Uhal, Bruce D., Uversky, Vladimir N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620871/ https://www.ncbi.nlm.nih.gov/pubmed/36417254 http://dx.doi.org/10.3390/epidemiologia3020018

Ejemplares similares

COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence
por: Hromić-Jahjefendić, Altijana, et al.
Publicado: (2023)

Periodically aperiodic pattern of SARS-CoV-2 mutations underpins the uncertainty of its origin and evolution
por: Hassan, Sk Sarif, et al.
Publicado: (2022)

Non-uniform aspects of the SARS-CoV-2 intraspecies evolution reopen question of its origin
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas
por: Barh, Debmalya, et al.
Publicado: (2021)

Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

Implications derived from S-protein variants of SARS-CoV-2 from six continents
por: Hassan, Sk. Sarif, et al.
Publicado: (2021)

COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?
por: Lundstrom, Kenneth, et al.
Publicado: (2021)

Autoimmunity roots of the thrombotic events after COVID-19 vaccination
por: Elrashdy, Fatma, et al.
Publicado: (2021)

Associations and Disease–Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review
por: Hromić-Jahjefendić, Altijana, et al.
Publicado: (2022)

The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19
por: Redwan, Elrashdy M., et al.
Publicado: (2021)

The importance of accessory protein variants in the pathogenicity of SARS-CoV-2
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2
por: Hassan, Sk. Sarif, et al.
Publicado: (2021)

A unique view of SARS-CoV-2 through the lens of ORF8 protein
por: Hassan, Sk Sarif, et al.
Publicado: (2021)

SARS‐CoV‐2 research using human pluripotent stem cells and organoids
por: Deguchi, Sayaka, et al.
Publicado: (2021)

SARS-CoV-2 Variants Show a Gradual Declining Pathogenicity and Pro-Inflammatory Cytokine Stimulation, an Increasing Antigenic and Anti-Inflammatory Cytokine Induction, and Rising Structural Protein Instability: A Minimal Number Genome-Based Approach
por: Barh, Debmalya, et al.
Publicado: (2022)

COVID-19 signalome: Potential therapeutic interventions
por: Lundstrom, Kenneth, et al.
Publicado: (2023)

Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2
por: Elrashdy, Fatma, et al.
Publicado: (2020)

Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
por: Elrashdy, Fatma, et al.
Publicado: (2020)

Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?
por: Hromić-Jahjefendić, Altijana, et al.
Publicado: (2023)

Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features
por: Hassan, Sk. Sarif, et al.
Publicado: (2020)

Predicting COVID-19—Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management
por: Barh, Debmalya, et al.
Publicado: (2021)

COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity
por: Lundstrom, Kenneth, et al.
Publicado: (2023)

Clinical utility of novel biosensing platform: Diagnosis of coronavirus SARS-CoV-2 at point of care
por: Aljabali, Alaa A.A., et al.
Publicado: (2021)

Natural resources to control COVID-19: could lactoferrin amend SARS-CoV-2 infectivity?
por: Mattar, Ehab H., et al.
Publicado: (2021)

Latent potentials of camel’s milk
por: Redwan, Elrashdy M., et al.
Publicado: (2022)

Urgent Need for Field Surveys of Coronaviruses in Southeast Asia to Understand the SARS-CoV-2 Phylogeny and Risk Assessment for Future Outbreaks †
por: Seyran, Murat, et al.
Publicado: (2021)

The Importance of Research on the Origin of SARS-CoV-2
por: Lundstrom, Kenneth, et al.
Publicado: (2020)

Questions concerning the proximal origin of SARS‐CoV‐2
por: Seyran, Murat, et al.
Publicado: (2020)

Looking at the carcinogenicity of human insulin analogues via the intrinsic disorder prism
por: Redwan, Elrashdy M., et al.
Publicado: (2016)

Simple and efficient protocol for immunoglobulin Y purification from chicken egg yolk
por: Redwan, Elrashdy M., et al.
Publicado: (2020)

Protein Intrinsic Disorder and Evolvability of MERS-CoV
por: Uversky, Vladimir N., et al.
Publicado: (2021)

SARS-CoV-2: A Master of Immune Evasion
por: Rubio-Casillas, Alberto, et al.
Publicado: (2022)

Hepatitis C Virus Infection and Intrinsic Disorder in the Signaling Pathways Induced by Toll-Like Receptors
por: Redwan, Elrashdy M., et al.
Publicado: (2022)

Does SARS-CoV-2 Induce IgG4 Synthesis to Evade the Immune System?
por: Rubio-Casillas, Alberto, et al.
Publicado: (2023)

Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics
por: Chavda, Vivek P., et al.
Publicado: (2023)

Alginate: Enhancement Strategies for Advanced Applications
por: Hurtado, Alejandro, et al.
Publicado: (2022)

The viral capsid as novel nanomaterials for drug delivery
por: Aljabali, Alaa AA, et al.
Publicado: (2021)

Structural disorder in the proteome and interactome of Alkhurma virus (ALKV)
por: Redwan, Elrashdy M., et al.
Publicado: (2018)

IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
por: Uversky, Vladimir N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qt60ieug3caog1si6deksvav3b